Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 01, 2025 CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an aggregate of 141,800 shares […]
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 GlobeNewswire July 01, 2025 SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New
Covenant Logistics Group, Inc. Announces Timing of Second Quarter Earnings Release an Conference Call GlobeNewswire July 01, 2025 CHATTANOOGA, Tenn., July 01, 2025 (GLOBE NEWSWIRE) — Covenant Logistics Group, Inc. (NYSE: CVLG) announced its plans to release its second quarter earnings after 4:00 p.m. Eastern time on Wednesday, July 23, 2025. Covenant Logistics Group, Inc.
(NASDAQ:LNSR), ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) — LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of directors granted three newly-hired non-executive employees an aggregate of 660 restricted stock units (“RSUs”). The RSUs were granted as of July 1, 2025, as inducement
Thornburg Income Builder Opportunities Trust (the “Trust”) (NASDAQ: TBLD) today announced a monthly distribution of $0.10417 per share on the Trust's common shares, payable on July 21, 2025, to common shareholders of record as of July 11, 2025. https://mma.prnewswire.com/media/1716788/Thornburg_Logo.jpg The Trust's monthly distribution is shown below: Amount Payable Date Ex-Dividend/Record Date Change from Previous Declaration$0.10417
Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”), today announced that the underwriters of its recent underwritten public offering have fully exercised their option to purchase an additional 11,250,000 ordinary shares, resulting in additional net proceeds to the Company of approximately $21.4 million, before estimated offering expenses. The exercise of the option closed
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 01, 2025 ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) — LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR's board of directors granted three newly-hired non-executive employees an aggregate of 660 restricted stock units
(NASDAQ:OZK),(NASDAQ:OZKAP), LITTLE ROCK, Ark., July 01, 2025 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) announced its Board of Directors declared a quarterly cash dividend on the Bank's common stock of $0.44 per share, up $0.01, or 2.33% from the prior quarter. The common stock dividend is payable on July 18, 2025 to shareholders
(NasdaqGM:ORKA), MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis (PsO), today announced the promotion of Laura Sandler to Chief Operating Officer. Ms. Sandler, who joined
Bank OZK Announces Increase to Quarterly Common Stock Dividend and Announces Preferred Stock Dividend Sixty consecutive quarters of increased quarterly cash dividend on its common stock GlobeNewswire July 01, 2025 LITTLE ROCK, Ark., July 01, 2025 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) announced its Board of Directors declared a quarterly cash dividend